Stockreport

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF - Partial spin-off of Bentrio® completed to increase focus on RNA delivery activities - Retains 49% in Altamira Medica AG, and secures 25% of future licensing revenue [Read more]